KuLGaP: A Selective Measure for Assessing Therapy Response in Patient-Derived Xenografts
Preprint
Abstract
Quantifying response to drug treatment in mouse models of human cancer is important for treatment development and assignment, and yet remains a challenging task. A preferred measure to quantify this response should take into account as much of the experimental data as possible, i.e. both tumor size over time and the variation among replicates. We propose a theoretically grounded measure, KuLGaP, to compute the difference between the treatment and control arms. KuLGaP is more selective than currently existing measures, reduces the risk of false positive calls and improves translation of the lab results to clinical practice.Keywords
This publication has 18 references indexed in Scilit:
- High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug responseNature Medicine, 2015
- The genomic landscape of response to EGFR blockade in colorectal cancerNature, 2015
- Ten Simple Rules for Reproducible Computational ResearchPLOS Computational Biology, 2013
- Area under the curve as a tool to measure kinetics of tumor growth in experimental animalsJournal of Immunological Methods, 2012
- On translation invariant operators which preserve the B-spline recurrenceAdvances in Computational Mathematics, 2006
- Reproducible Research: A Bioinformatics Case StudyStatistical Applications in Genetics and Molecular Biology, 2005
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000
- About distances of discrete distributions satisfying the data processing theorem of information theoryIEEE Transactions on Information Theory, 1997
- On Information and SufficiencyThe Annals of Mathematical Statistics, 1951